NCT07329283

Brief Summary

Sleep is an important factor for overall health. This study will see how different light exposure patterns and food intake impact a person's metabolism (how the body breaks down food) when sleeping is reduced. Participants will attend 6 to 8 in-person visits to the study clinic, including three overnight stays. People will complete surveys and medical tests. The study will last about 4 to 6 months.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
60mo left

Started Dec 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress9%
Dec 2025May 2031

First Submitted

Initial submission to the registry

December 11, 2025

Completed
8 days until next milestone

Study Start

First participant enrolled

December 19, 2025

Completed
21 days until next milestone

First Posted

Study publicly available on registry

January 9, 2026

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2030

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2031

Last Updated

January 22, 2026

Status Verified

January 1, 2026

Enrollment Period

4.4 years

First QC Date

December 11, 2025

Last Update Submit

January 20, 2026

Conditions

Keywords

SleepLight ExposureMetabolismCircadian RhythmFood IntakeLifestyle FactorsSleep Hygiene

Outcome Measures

Primary Outcomes (2)

  • Insulin Sensitivity

    Insulin sensitivity will be measured by intravenous glucose tolerance tests.

    Immediately following the 5-day sleep restriction segment

  • Internal Circadian Misalignment (Uridine and Isobutyryl-L-carnitine)

    Phase angle between DLMO and acrophase of uridine and isobutyryl-L-carnitine during constant routine.

    During the constant routine, following the 5-day sleep restriction segment

Other Outcomes (2)

  • Timing of DLMO and DLMOff

    During the constant routine, following the 5-day sleep restriction segment

  • Hunger and Satiety Visual Analog Scales

    During the constant routine, following the 5-day sleep restriction segment

Study Arms (3)

Sleep Restriction with Central and Peripheral Alignment

NO INTERVENTION

(Arm "A")-Control condition with central and peripheral aligned circadian rhythms

Sleep Restriction with Central Clock Misalignment

EXPERIMENTAL

(Arm "B")-Misalignment of the central clock by nighttime electrical light exposure and dim-light in morning hours.

Behavioral: Central Clock Misalignment

Sleep Restriction with Peripheral Misalignment

EXPERIMENTAL

(Arm "C")-Misalignment of peripheral oscillators by shifting the majority of food intake to the nighttime hours.

Behavioral: Peripheral Misalignment

Interventions

Light exposure will be dimmed during the first 4 hours of scheduled wakefulness, with bright light exposure during the nighttime hours of extended wakefulness.

Sleep Restriction with Central Clock Misalignment

Most daily calories will be given later in the day to shift eating patterns toward the nighttime hours.

Sleep Restriction with Peripheral Misalignment

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age: 18-35 years old; equal numbers of men and women
  • Body Mass Index (BMI): 18.5-24.9 kg/m2
  • Sleep Habits: habitual self-reported average total sleep time (TST) 7-9 hours per night for prior 6 months

You may not qualify if:

  • Clinically diagnosed sleep disorder or apnea hypopnea index (AHI) ≥5
  • Evidence of significant organ system dysfunction or disease (e.g., heart disease, diabetes)
  • Fasting plasma glucose ≥100 mg/dL
  • Major psychiatric illness (e.g., major depressive disorder)
  • Cancer that has been in remission less than 5 years
  • History of shift-work in prior year
  • Weight change \>5% of body weight over prior six months
  • Currently following a weight-loss program
  • Menopause
  • Pregnant/nursing
  • Greater than 5-day variation in menstrual cycle length month-to-month
  • Currently smoking
  • Alcohol intake \>14 drinks/week or \>3 drinks/day.
  • Use of prescription medications (except oral contraceptives) within one month prior to or during in-lab visits.
  • Consumption of illegal drugs or \>500mg per day of caffeine.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

College of Health Research Complex - University of Utah, Salt Lake City 84112

Salt Lake City, Utah, 84112, United States

RECRUITING

MeSH Terms

Conditions

Sleep HygieneSleep DeprivationChronobiology Disorders

Condition Hierarchy (Ancestors)

Health BehaviorBehaviorDyssomniasSleep Wake DisordersNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Study Officials

  • Christopher Depner, PhD

    University of Utah

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Randomization to condition order will be concealed to research staff and participants until the conclusion of the condition "A", which all participants will complete first.
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

December 11, 2025

First Posted

January 9, 2026

Study Start

December 19, 2025

Primary Completion (Estimated)

May 31, 2030

Study Completion (Estimated)

May 31, 2031

Last Updated

January 22, 2026

Record last verified: 2026-01

Locations